Shandong Xinhua Pharmaceutical Company Limited

SEHK:719 Stock Report

Market Cap: HK$9.2b

Shandong Xinhua Pharmaceutical Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure1.6yrs
Board average tenure2.4yrs

Recent management updates

Recent updates

Insufficient Growth At Shandong Xinhua Pharmaceutical Company Limited (HKG:719) Hampers Share Price

Jan 23
Insufficient Growth At Shandong Xinhua Pharmaceutical Company Limited (HKG:719) Hampers Share Price

Shandong Xinhua Pharmaceutical (HKG:719) Takes On Some Risk With Its Use Of Debt

Mar 07
Shandong Xinhua Pharmaceutical (HKG:719) Takes On Some Risk With Its Use Of Debt

Is Shandong Xinhua Pharmaceutical (HKG:719) Using Too Much Debt?

Nov 18
Is Shandong Xinhua Pharmaceutical (HKG:719) Using Too Much Debt?

These 4 Measures Indicate That Shandong Xinhua Pharmaceutical (HKG:719) Is Using Debt Extensively

Jul 27
These 4 Measures Indicate That Shandong Xinhua Pharmaceutical (HKG:719) Is Using Debt Extensively

Shandong Xinhua Pharmaceutical (HKG:719) Has Affirmed Its Dividend Of HK$0.18

Jul 04
Shandong Xinhua Pharmaceutical (HKG:719) Has Affirmed Its Dividend Of HK$0.18

Estimating The Intrinsic Value Of Shandong Xinhua Pharmaceutical Company Limited (HKG:719)

Mar 09
Estimating The Intrinsic Value Of Shandong Xinhua Pharmaceutical Company Limited (HKG:719)

We Think Shandong Xinhua Pharmaceutical (HKG:719) Can Stay On Top Of Its Debt

Dec 21
We Think Shandong Xinhua Pharmaceutical (HKG:719) Can Stay On Top Of Its Debt

Does Shandong Xinhua Pharmaceutical (HKG:719) Deserve A Spot On Your Watchlist?

Apr 06
Does Shandong Xinhua Pharmaceutical (HKG:719) Deserve A Spot On Your Watchlist?

What Kind Of Shareholders Own Shandong Xinhua Pharmaceutical Company Limited (HKG:719)?

Mar 19
What Kind Of Shareholders Own Shandong Xinhua Pharmaceutical Company Limited (HKG:719)?

Is Shandong Xinhua Pharmaceutical (HKG:719) A Risky Investment?

Feb 26
Is Shandong Xinhua Pharmaceutical (HKG:719) A Risky Investment?

Are Shandong Xinhua Pharmaceutical's (HKG:719) Statutory Earnings A Good Guide To Its Underlying Profitability?

Feb 05
Are Shandong Xinhua Pharmaceutical's (HKG:719) Statutory Earnings A Good Guide To Its Underlying Profitability?

Shandong Xinhua Pharmaceutical (HKG:719) Share Prices Have Dropped 43% In The Last Three Years

Jan 18
Shandong Xinhua Pharmaceutical (HKG:719) Share Prices Have Dropped 43% In The Last Three Years

Is Shandong Xinhua Pharmaceutical Company Limited (HKG:719) A Smart Pick For Income Investors?

Dec 29
Is Shandong Xinhua Pharmaceutical Company Limited (HKG:719) A Smart Pick For Income Investors?

Do Institutions Own Shandong Xinhua Pharmaceutical Company Limited (HKG:719) Shares?

Dec 14
Do Institutions Own Shandong Xinhua Pharmaceutical Company Limited (HKG:719) Shares?

Is Shandong Xinhua Pharmaceutical (HKG:719) Using Too Much Debt?

Nov 26
Is Shandong Xinhua Pharmaceutical (HKG:719) Using Too Much Debt?

CEO

Shandong Xinhua Pharmaceutical has no CEO, or we have no data on them.


Leadership Team

NamePositionTenureCompensationOwnership
Tongqing He
Chairman & Deputy GM3.3yrsCN¥1.28m0.043%
CN¥ 3.9m
Ning Hou
CFO, Financial Controller & Executive Directorno dataCN¥1.23m0.048%
CN¥ 4.4m
Wenhui Xu
Executive Director1.5yrsCN¥1.25m0.035%
CN¥ 3.3m
Haifeng Guo
Head of Accounting Departmentno datano datano data
Xiaohong He
Chief of Finance Departmentno datano datano data
Changsheng Wei
Deputy GM & Manager of Administrative Personnel Departmentno dataCN¥1.05m0.020%
CN¥ 1.8m
Xuesong Liu
Deputy General Manager1.6yrsno data0.0034%
CN¥ 311.1k
Changqiu Cao
Company Secretary15.3yrsCN¥344.30k0.020%
CN¥ 1.8m

1.6yrs

Average Tenure

52yo

Average Age

Experienced Management: 719's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Tongqing He
Chairman & Deputy GM3.3yrsCN¥1.28m0.043%
CN¥ 3.9m
Ning Hou
CFO, Financial Controller & Executive Director1.5yrsCN¥1.23m0.048%
CN¥ 4.4m
Wenhui Xu
Executive Director1.5yrsCN¥1.25m0.035%
CN¥ 3.3m
Zhichao Tao
Independent Supervisor21.8yrsCN¥24.00kno data
Lie Xu
Non-Executive Director13.8yrsCN¥1.25m0.043%
CN¥ 3.9m
Guangcheng Pan
Independent Non-Executive Director3.3yrsCN¥100.00kno data
Chengtong Liu
Chairman of Supervisory Committee3.3yrsno datano data
Jianwei Zhu
Independent Non-Executive Director3.3yrsCN¥100.00kno data
Peixue Ling
Non-Executive Director1.5yrsCN¥16.67kno data
Chengyong Zhang
Non-Independent Directorless than a yearno datano data
Jingjing Zhang
Non-Executive Directorless than a yearno datano data
Ching Ching Cheung
Independent Non-Executive Directorless than a yearno datano data

2.4yrs

Average Tenure

53yo

Average Age

Experienced Board: 719's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.